Profile
Cedric O'Gorman formerly worked at Axsome Therapeutics, Inc., as Senior VP-Clinical Development & Medical Affairs, Intra-Cellular Therapies, Inc., as Vice President-Medical Affairs from 2014 to 2017, Relmada Therapeutics, Inc., as Chief Medical Officer from 2023 to 2024, and Alpha Cognition, Inc., as Chief Medical Officer from 2021 to 2023.
Dr. O'Gorman received his doctorate degree from National University of Ireland and Masters Business Admin degree in 2010 from The Leonard N Stern School of Business.
Former positions of Cedric O'Gorman
| Companies | Position | End |
|---|---|---|
| RELMADA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 02/01/2024 |
| ALPHA COGNITION INC. | Chief Tech/Sci/R&D Officer | 05/01/2023 |
| AXSOME THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/12/2021 |
| INTRA-CELLULAR THERAPIES, INC. | Chief Tech/Sci/R&D Officer | 31/08/2017 |
Training of Cedric O'Gorman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Axsome Therapeutics, Inc.
Axsome Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures novel therapies for the management of central nervous system | Health Technology |
National University of Ireland
National University of Ireland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intra-Cellular Therapies, Inc.
Intra-Cellular Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes small molecule drugs to treat neuropsychiatric and neurological disorders | Health Technology |
The Leonard N Stern School of Business
The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Relmada Therapeutics, Inc.
Relmada Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products for the treatment of depression and other central nervous system diseases | Health Technology |
Alpha Cognition, Inc.
Alpha Cognition, Inc. Financial ConglomeratesFinance Develops pharmaceutical products for treating neurodegenerative diseases | Finance |
- Stock Market
- Insiders
- Cedric O'Gorman
















